Clinical trial
The Efficacy and Safety of Oral Minocycline in the Treatment of Retinitis Pigmentosa: An Open-label Clinical Trial
NCT04068207 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Oral Minocycline in the Treatment of Retinitis Pigmentosa: An Open-label Clinical Trial
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 25, 2019
- Completion date
- December 1, 2023
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inherited retinal dystrophy, retina disorder, retinitis pigmentosa